Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
BACKGROUND: Reprimo (RPRM), a highly glycosylated protein, is a new downstream effector of p53-induced cell cycle arrest at the G2/M checkpoint, and a putative tumor suppressor gene frequently silenced via methylation of its promoter region in several malignances. The aim of this study was to charac...
Guardado en:
Autores principales: | Buchegger,Kurt, Ili,Carmen, Riquelme,Ismael, Letelier,Pablo, Corvalán,Alejandro H., Brebi,Priscilla, Huang,Tim Hui-Ming, Roa,Juan Carlos |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2016
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100005 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Isolation of Breast Cancer Stem Cell from MDA-MB231 Cell Line Using Vincristine
por: Ghanbari,Tara, et al.
Publicado: (2016) -
Internalized Nanoceria Modify the Radiation-Sensitivity Profile of MDA MB231 Breast Carcinoma Cells
por: Emory Bibb, et al.
Publicado: (2021) -
Characterization and Cytotoxicity of Pseudomonas Mediated Rhamnolipids Against Breast Cancer MDA-MB-231 Cell Line
por: Neelam Mishra, et al.
Publicado: (2021) -
Bio-informatics and in Vitro Experiments Reveal the Mechanism of Schisandrin A Against MDA-MB-231 cells
por: Ling Chen, et al.
Publicado: (2021) -
Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling
por: Anjugam Paramanantham, et al.
Publicado: (2021)